CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,020,980 | +9.2% | 359,500 | 0.0% | 0.01% | +20.0% |
Q2 2023 | $934,700 | +42.9% | 359,500 | 0.0% | 0.01% | +25.0% |
Q1 2023 | $654,290 | +10.3% | 359,500 | 0.0% | 0.00% | +33.3% |
Q4 2022 | $593,175 | -14.0% | 359,500 | 0.0% | 0.00% | -25.0% |
Q3 2022 | $690,000 | -35.8% | 359,500 | 0.0% | 0.00% | -76.5% |
Q2 2022 | $1,075,000 | – | 359,500 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 4,840,413 | $84,949,000 | 4.39% |
ACUTA CAPITAL PARTNERS, LLC | 391,974 | $6,879,000 | 2.43% |
Ally Bridge Group (NY) LLC | 319,538 | $5,608,000 | 1.65% |
RA Capital Management | 3,350,506 | $58,801,000 | 0.82% |
Avidity Partners Management LP | 1,683,441 | $29,544,000 | 0.66% |
Sofinnova Investments, Inc. | 246,321 | $4,323,000 | 0.26% |
CAAS CAPITAL MANAGEMENT LP | 579,746 | $10,175,000 | 0.20% |
SPHERA FUNDS MANAGEMENT LTD. | 135,145 | $2,372,000 | 0.20% |
ACT CAPITAL MANAGEMENT, LLC | 15,000 | $263,000 | 0.14% |
Baker Brothers Advisors | 812,640 | $14,262,000 | 0.06% |